IPO Details

Bidding Dates

01 Sep '25 - 03 Sep '25

Minimum Investment

₹14,994/ 1 Lot (119 Shares)

Price Range

₹120 -₹126

Maximum Investment

₹1,94,922/ 2 Lots (1,547 Shares)

Retail Discount

To be announced

Issue Size

₹126.00 Cr

Investor category and sub category

Retail Individual Investors (RII)  |   Non-institutional Investors (NII)  |   Qualified Institutional Buyers (QIB)  |  

Amanta Healthcare IPO Important Dates

Important dates with respect to IPO allotment and listing

IPO Opening Date

Sep 01, 25

IPO Closing Date

Sep 03, 25

Basis of Allotment

Sep 04, 25

Initiation of Refunds

Sep 08, 25

IPO Listing Date

Sep 09, 25

IPO Subscription Details

DateQIBNIIRetailEMPTotal

Day 1Aug 31, 2025

 0.04 5.82 6.72 4.62

About Amanta Healthcare IPO

Amanta Healthcare IPO is a book build issue worth ₹126.00 crore. The entire issue consists of a fresh issue of 1.00 crore equity shares amounting to ₹126.00 crore. The IPO will open for subscription on September 1, 2025, and close on September 3, 2025. 

The allotment of shares is expected to be finalised on September 4, 2025, and the shares are likely to be listed on BSE and NSE with a tentative listing date set for September 9, 2025. The price band for Amanta Healthcare IPO is fixed between ₹120.00 and ₹126.00 per share. 

The minimum lot size is 119 shares, requiring a retail investor to invest at least ₹14,994 at the upper price band. For non-institutional investors, the lot size investment differs: sNII is required to apply for 14 lots (1,666 shares) amounting to ₹2,09,916, while bNII needs to apply for 67 lots (7,973 shares) worth ₹10,04,598.

Beeline Capital Advisors Private Limited is acting as the book running lead manager for this issue, while MUFG Intime India Private Limited has been appointed as the registrar.

Amanta Healthcare IPO Objectives 

The company plans to allocate the net proceeds from the issuance to the following purposes:

  1. To fund capital expenditure for civil construction and purchase of equipment, plant, and machinery for setting up a new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat.
  2. To fund capital expenditure for civil construction and purchase of equipment, plant, and machinery for setting up a new manufacturing line for SVP at Hariyala, Kheda, Gujarat. 
  3. The company plans to allocate funds towards overall business growth, strengthening operations, and supporting future opportunities.

About Amanta Healthcare Limited 

Amanta Healthcare Limited is a pharmaceutical company focused on developing, manufacturing, and marketing a wide range of sterile liquid products. The company specialises in parenteral products packed in plastic containers using Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) technology. 

Its portfolio includes both Large Volume Parenterals (LVPs) and Small Volume Parenterals (SVPs), along with medical devices. The therapeutic segments covered include fluid therapy (IV fluids), formulations, diluents, ophthalmic, respiratory care, and irrigation solutions. 

In the medical devices category, the company produces irrigation solutions, first-aid solutions, and eye lubricants. The company provides multiple closure systems such as nipple head, twist-off, leur-lock, and screw types, with container sizes ranging from 2 ml to 1000 ml. 

Supported by dedicated formulation and development (F&D) and quality control laboratories in Hariyala, District Kheda, Gujarat, the company works on both new formulations and improvements to existing ones. Its manufacturing facilities hold GMP certifications from global regulatory authorities, including WHO-recommended standards, and are approved for exports by several countries.

Amanta Healthcare markets products under its own brands in India through a strong network of 316 distributors and stockists, while also exporting to 19 countries across Africa, Latin America, the UK, and other regions. With a portfolio of 47 products registered in 112 international jurisdictions, the company operates through three key business units: national sales, international sales, and product partnering. 

Its experienced management team and skilled workforce of professionals continue to support innovation, regulatory compliance, and growth in the pharmaceutical sector.

Industry Outlook

  1. Global healthcare expenditure touched US$ 9.8 trillion in 2021, accounting for ~10% of global GDP. Rising chronic diseases, lifestyle changes, and increasing access to healthcare are expected to drive further growth in the pharmaceutical industry. 
  2. India’s pharmaceutical formulation exports reached USD 12.3 billion to regulated markets in fiscal 2024, with the US contributing ~66% and Europe ~24%. Exports to semi-regulated markets stood at USD 10.1 billion, driven by Africa, Asia, Russia, and Latin America. Formulation exports are projected to grow 6–8% in fiscal 2025, supported by new launches and easing pricing pressures.
  3. Exports to regulated markets are expected to grow by 11–13% in fiscal 2025, aided by new product launches in the US, demand from Europe, and rising opportunities in Canada and Japan.

How To Apply for the Amanta Healthcare IPO Online?

  1. Login to Your Angel One Account: Open the Angel One app or website and log in with your credentials.
  2. Locate the IPO Section: Navigate to the 'IPO' section on the platform.
  3. Select IPO: Find and select the Amanta Healthcare IPO from the list of open IPOs.
  4. Enter the Lot Size: Specify the number of lots you want to bid for.
  5. Submit Your UPI ID: Enter your UPI ID to link your payment method and submit your application.
  6. Approve Funds: Once you receive the bid request on your UPI app, approve it by entering your UPI PIN.

How To Check the Allotment Status of Amanta Healthcare IPO?

Steps to check IPO allotment status on Angel One’s app:

  1. Log in to the Angel One app.
  2. Go to the IPO Section and then to IPO Orders.
  3. Select the individual IPO that you had applied for and check the allotment status.
  4. Angel One will notify you of your IPO allotment status via push notification and email.

Contact Details of Amanta Healthcare Limited 

Registered office: 8th Floor, Shaligram Corporates, C.J. Marg, Ambli, Ahmedabad –380058, Gujarat, India

Phone: 079 67777600

E-mail:cs@amanta.co.in

Amanta Healthcare IPO Reservation

Investor Category

Shares Offered

QIB Shares 

Not more than 50.00% of the Net Issue

Retail Shares

Not less than 35.00% of the Net Issue

NII Shares

Not less than 15.00% of the Net Issue

Amanta Healthcare IPO Lot Size Details

Application

Lots

Shares

Amount

Retail (Min)

1

119

₹14,994

Retail (Max)

13

1,547

₹1,94,922

S-HNI (Min)

14

1,666

₹2,09,916

S-HNI (Max)

66

7,854

₹9,89,604

B-HNI (Min)

67

7,973

₹10,04,598

Amanta Healthcare IPO Promoter Holding

The promoters of the company include Bhavesh Patel, Vishal Patel, Jayshreeben Patel, Jitendra Kumar Patel and Milcent Appliances Private Limited.

Share Holding Pre-Issue

85.60%

Share Holding Post Issue

63.56%

Note: Equity dilution will be determined by subtracting the Shareholding Post Issue from the Shareholding Pre Issue.

Key Performance Indicators for Amanta Healthcare IPO

KPI

Value

ROE (%)

12.42

RoCE (%)

13.72

Debt/Equity

2.02

PAT Margin (%)

3.86

EBITDA Margin (%)

22.11

Amanta Healthcare IPO Prospectus

Amanta Healthcare IPO Registrar and Lead Managers

Amanta Healthcare IPO Lead Managers

  • Beeline Capital Advisors Private Limited

Registrar for Amanta Healthcare IPO

MUFG Intime India Private Limited

Financial Performance of Amanta Healthcare Limited

Particulars Year ending on March 31, 2024 Year ending on March 31, 2023 Year ending on March 31, 2022
Revenue from Operation (in ₹ lakh) 28,034.03 25,912.93 22,544.13
Profit/loss After Tax (in ₹ lakh) 363.32 (211.06) 5,388.17
Net Worth (in ₹ lakh) 6,628.88 6,288.34 6,497.24
Total Borrowings (in ₹ lakh) 20,522.91 21,565.85 22,170.41
Return on Equity (%) 5.27 (3.27) 141.82
Return on Capital Employed (RoCE) (%) 12.76 12.19 35.44
EBITDA (in ₹ lakh) 5,875.65 5,630.67 5,445.58

Know before investing

Strengths

8

  1. Incorporated in 1994, with 30 years’ experience in pharmaceutical manufacturing excellence.

  2. Wide product portfolio spanning six therapeutic segments ensures steady business sustainability.

  3. Registered 47 products across 112 international jurisdictions, strengthening global market presence.

  4. Manufacturing facility spread over 66,852 sq. meters with advanced infrastructure.

  5. Equipped with four LVP and three SVP lines using ABFS/ISBM technology.

  6. Strong domestic reach through 316 distributors and 108-member sales and marketing team.

  7. Supported by over 509 employees, including skilled scientists and technical professionals.

  8. Product portfolio increased from 41 in FY22 to 47 in FY24.

Risks

8

  1. Since Amanta Healthcare Limited operates its entire manufacturing facility from a single location in Hariyala, Kheda, Gujarat, the company is highly dependent on this one site for its operations.

  2. Shutdowns from power shortages, machinery breakdowns or disasters may disrupt operations.

  3. Quality concerns or delayed deliveries may cancel orders and affect revenues.

  4. Heavy dependence on imported plastic granules exposes business to price fluctuations.

  5. In 1995, 10,44,675 equity shares were allotted to 68 persons.

  6. The facility faced 20 inspections till Dec 31, 2024, risking regulatory actions.

  7. Leased offices and warehouses pose risks if renewals become commercially unfavorable.

  8. Extensive pharmaceutical regulations globally may increase compliance costs and legal liabilities.

  • How to Apply in IPO
  • How to Check IPO Allotment Status
Play Button

Login to Angel One App / Website & click on IPO

Select desired IPO & tap on "Apply"

Enter UPI ID, set quantity/price & submit

Accept mandate on the UPI app to complete the process

Play Button

Login to Angel One App / Website

Choose IPO section on Home Page

Click IPO Orders

Chose the IPO application you want to view the status for

Amanta Healthcare Limited Peer Comparison

Company Name Total Income (₹ in lakhs) Face Value (₹) RoNW (%) NAV per Equity Share (₹)
Amanta Healthcare Limited 28,160.68 10.00 5.48 24.71
Denis Chem Lab Limited 16,920.97 10.00 13.88 57.91

Amanta Healthcare IPO FAQs

What is the Amanta Healthcare IPO?

Amanta Healthcare IPO is a book built issue IPO. It runs from September 1, 2025, to September 3, 2025.

When will the Amanta Healthcare IPO be allotted?

The Basis of Allotment will happen on Thursday, September 4, 2025.

When will the Amanta Healthcare IPO open for subscription?

The IPO subscription window will open on September 1, 2025.

What minimum lot size can retail investors subscribe to?

The minimum lot size retail investors can subscribe to is 1 lot, and the lot size is 119 shares.

When will the Amanta Healthcare IPO list on exchanges?

The listing date for Amanta Healthcare IPO is Tuesday, September 9, 2025.

What is the issue size of the Amanta Healthcare IPO?

The issue size of the Amanta Healthcare IPO is ₹126.00 crore.

What are the open and close dates of the Amanta Healthcare IPO?

The open and close dates for Amanta Healthcare IPO are from September 1, 2025, to September 3, 2025.

What would be the listing gains on the Amanta Healthcare IPO?

Listing gains cannot be ascertained before the listing of the IPO on the stock exchange.

When will I know if my Amanta Healthcare IPO order is placed?

You will receive a notification once your order is successfully placed with the exchange after the bidding starts.

Who is the registrar of Amanta Healthcare IPO?

MUFG Intime India Private Limited is the registrar responsible for managing the IPO allotment process and handling investor queries.

Where is the Amanta Healthcare IPO getting listed?

The Amanta Healthcare IPO is proposed to be listed on the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE).

How to increase your chances of getting a Amanta Healthcare IPO allotment?

  1. Multiple Submissions: Use different Demat accounts to make multiple applications.
  2. Higher Price Band Bidding: Opt for bidding at the cut-off price or higher price band.
  3. Timely Subscription: Ensure you subscribe to the IPO within the specified time frame.

How do I approve the UPI mandate request for the Amanta Healthcare IPO?

You must complete the payment process by logging in to your UPI handle and approving the payment mandate. 

 

Can I submit more than one application for the public issue of Amanta Healthcare IPO using one PAN?

You can submit only one application using your PAN card. 

 

How to read Amanta Healthcare Limited's financial statements?

To read Amanta Healthcare Limited’s financial statements, download the IPO’s  RHP document. 

 

What is 'pre-apply' for the Amanta Healthcare IPO?

Pre-apply allows investors to apply for the Amanta Healthcare IPO two days before the subscription period opens, ensuring an early submission of your application. 

 

If I pre-apply for the Amanta Healthcare IPO, when will my order get placed?

Your order will be placed when the IPO opens for bidding, and a UPI request will follow within 24 hours.